Ordering PathVysion From Your Lab

HER-2 status assessment is now considered standard of care in the selection of therapy for breast cancer. Some laboratories continue to use IHC to assess HER-2 status. To ensure testing is performed with the most accurate and reliable HER-2 method, request PathVysion, specifically, on the laboratory requisition form.